[Cite as http://purl.org/au-research/grants/nhmrc/508088]
A/Pr Michael Beard
Dr Karla Helbig
Prof Eric Gowans
Brief description The only treatment for hepatitis C is Interferon-ribavirin combination therapy. Interferon works by stimulating the liver cells to produce antiviral proteins that can control hepatitis C virus replication, however we do not know which proteins are responsible. The aim of this proposal is to identify those proteins that can limit HCV replication using both a laboratory based and clinical approach and to identify markers that will predict treatment outcome.
Funding Amount $AUD 389,224.94
Funding Scheme NHMRC Project Grants
Standard Project Grant